CONMED Corporation
CNMD
$58.29
-$0.6278-1.07%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.78% | 3.98% | 4.55% | 5.69% | 30.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.78% | 3.98% | 4.55% | 5.69% | 30.37% |
| Cost of Revenue | 3.38% | 2.52% | 2.49% | 2.03% | 22.12% |
| Gross Profit | 7.63% | 5.13% | 6.27% | 8.80% | 37.56% |
| SG&A Expenses | 2.60% | 3.80% | 0.71% | 3.39% | 19.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.57% | 3.39% | 1.75% | 2.94% | 20.77% |
| Operating Income | 27.47% | 8.42% | 32.36% | 40.93% | 181.46% |
| Income Before Tax | 7.27% | 178.36% | 115.34% | 940.06% | 486.06% |
| Income Tax Expenses | 29.89% | 68.11% | 104.34% | 813.60% | 120.51% |
| Earnings from Continuing Operations | 2.07% | 209.30% | 118.29% | 983.51% | 24.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.07% | 209.30% | 118.29% | 983.51% | 24.40% |
| EBIT | 27.47% | 8.42% | 32.36% | 40.93% | 181.46% |
| EBITDA | 20.33% | 5.80% | 19.46% | 22.50% | 90.96% |
| EPS Basic | 1.53% | 208.13% | 117.19% | 974.33% | 23.29% |
| Normalized Basic EPS | 36.72% | 14.27% | 50.76% | 83.13% | 550.05% |
| EPS Diluted | 2.79% | 214.00% | 123.26% | 957.05% | 21.28% |
| Normalized Diluted EPS | 39.03% | 16.82% | 54.83% | 84.41% | 544.14% |
| Average Basic Shares Outstanding | 0.54% | 0.37% | 0.49% | 0.88% | 0.90% |
| Average Diluted Shares Outstanding | -1.13% | -1.82% | -2.17% | 0.22% | 1.85% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.02% | -0.68% | -0.54% | -0.91% | -0.19% |
